Data Insights

Sirolimus albumin-bound by Aadi Bioscience for Leiomyosarcoma: Likelihood of Approval

Sirolimus albumin-bound is under clinical development by Aadi Bioscience and currently in Phase II for Leiomyosarcoma. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - Sirolimus Albumin-bound in Leiomyosarcoma

Data Insights

Sirolimus albumin-bound by Aadi Bioscience for Pleomorphic Liposarcoma: Likelihood of Approval

Sirolimus albumin-bound is under clinical development by Aadi Bioscience and currently in Phase II for Pleomorphic Liposarcoma. According to GlobalData,...

Likelihood of Approval and Phase Transition Success Rate Model - Sirolimus Albumin-bound in Pleomorphic Liposarcoma

Data Insights

Sirolimus albumin-bound by Aadi Bioscience for Metastatic Colorectal Cancer: Likelihood of Approval

Sirolimus albumin-bound is under clinical development by Aadi Bioscience and currently in Phase II for Metastatic Colorectal Cancer. According to...

Likelihood of Approval and Phase Transition Success Rate Model - Sirolimus Albumin-bound in Metastatic Colorectal Cancer

Data Insights

Sirolimus albumin-bound by Aadi Bioscience for Gastroesophageal (GE) Junction Carcinomas: Likelihood of Approval

Sirolimus albumin-bound is under clinical development by Aadi Bioscience and currently in Phase II for Gastroesophageal (GE) Junction Carcinomas. According...

Likelihood of Approval and Phase Transition Success Rate Model - Sirolimus Albumin-bound in Gastroesophageal (GE) Junction Carcinomas

Data Insights

Sirolimus albumin-bound by Aadi Bioscience for Non-Small Cell Lung Cancer: Likelihood of Approval

Sirolimus albumin-bound is under clinical development by Aadi Bioscience and currently in Phase II for Non-Small Cell Lung Cancer. According...

Likelihood of Approval and Phase Transition Success Rate Model - Sirolimus Albumin-bound in Non-Small Cell Lung Cancer

Data Insights

Sirolimus albumin-bound by Aadi Bioscience for Renal Cell Carcinoma: Likelihood of Approval

Sirolimus albumin-bound is under clinical development by Aadi Bioscience and currently in Phase II for Renal Cell Carcinoma. According to...

Likelihood of Approval and Phase Transition Success Rate Model - Sirolimus Albumin-bound in Renal Cell Carcinoma

Data Insights

Sirolimus albumin-bound by Aadi Bioscience for Ewing Sarcoma: Likelihood of Approval

Sirolimus albumin-bound is under clinical development by Aadi Bioscience and currently in Phase II for Ewing Sarcoma. According to GlobalData,...

Likelihood of Approval and Phase Transition Success Rate Model - Sirolimus Albumin-bound in Ewing Sarcoma

Data Insights

Sirolimus albumin-bound by Aadi Bioscience for Melanoma: Likelihood of Approval

Sirolimus albumin-bound is under clinical development by Aadi Bioscience and currently in Phase II for Melanoma. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - Sirolimus Albumin-bound in Melanoma

Data Insights

Sirolimus albumin-bound by Aadi Bioscience for Uterine Cancer: Likelihood of Approval

Sirolimus albumin-bound is under clinical development by Aadi Bioscience and currently in Phase II for Uterine Cancer. According to GlobalData,...

Likelihood of Approval and Phase Transition Success Rate Model - Sirolimus Albumin-bound in Uterine Cancer

Data Insights

Sirolimus albumin-bound by Aadi Bioscience for Ovarian Cancer: Likelihood of Approval

Sirolimus albumin-bound is under clinical development by Aadi Bioscience and currently in Phase II for Ovarian Cancer. According to GlobalData,...

Likelihood of Approval and Phase Transition Success Rate Model - Sirolimus Albumin-bound in Ovarian Cancer

Data Insights

Sirolimus albumin-bound by Aadi Bioscience for Solid Tumor: Likelihood of Approval

Sirolimus albumin-bound is under clinical development by Aadi Bioscience and currently in Phase II for Solid Tumor. According to GlobalData,...

Likelihood of Approval and Phase Transition Success Rate Model - Sirolimus Albumin-bound in Solid Tumor

Data Insights

Sirolimus albumin-bound by Aadi Bioscience for Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET): Likelihood of Approval

Sirolimus albumin-bound is under clinical development by Aadi Bioscience and currently in Phase II for Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET). According...

Likelihood of Approval and Phase Transition Success Rate Model - Sirolimus Albumin-bound in Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET)

Data Insights

Sirolimus albumin-bound by Aadi Bioscience for Chondrosarcoma: Likelihood of Approval

Sirolimus albumin-bound is under clinical development by Aadi Bioscience and currently in Phase II for Chondrosarcoma. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - Sirolimus Albumin-bound in Chondrosarcoma